Last Updated: 04/02/2025

Malaria immunity and the elimination of malaria and drug resistance

Objectives

The aim of this project is to determine the impact of Mass Drug Administration (MDA) on immunity and patterns of malaria and drug resistance in order to inform Mass Drug Administration policy.

Principal Institution

Burnet Institute, Australia

Principal Investigators / Focal Persons

Freya JI Fowkes

Rationale and Abstract

Significant obstacles to achieving malaria elimination include increasing drug resistance and undetected malaria parasites. Mass Drug Administration, is a potential intervention to eliminate undetected malaria but there are concerns it may cause rebounds in clinical malaria due to loss of naturally acquired immunity.

Date

Jan 2019 — Dec 2021

Total Project Funding

$450,324

Country / Project Site(s)

Australia
Thailand

SHARE
SHARE